Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

1.2K
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.2K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

1.2K
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.2K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

2.9K
The pathophysiology of pneumonia involves the following steps:
2.9K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

3.5K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.5K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

931
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
931
Pathophysiology of Vomiting01:22

Pathophysiology of Vomiting

3.0K
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The perineurium integrates leptin with its sympathetic outflow to protect against obesity.

Nature metabolism·2026
Same author

Gα<sub>q</sub> Is a Heterotrimeric G-Protein Subunit That Directs the Selectivity of PPARγ-Induced Gene Pathways Toward Energy-Related Processes Rather than Adiposity.

Metabolites·2026
Same author

Publisher Correction: GLP-1R-GIPR-PPARα/γ/δ quintuple agonism corrects obesity and diabetes in mice.

Nature·2026
Same author

GLP-1R-GIPR-PPARα/γ/δ quintuple agonism corrects obesity and diabetes in mice.

Nature·2026
Same author

Exoproteome of calorie-restricted humans identifies complement deactivation as an immunometabolic checkpoint reducing inflammaging.

Nature aging·2026
Same author

Adipocytes signal to recruit specific mRNAs from surrounding cells to restore expression deficits.

Nature communications·2026

Related Experiment Video

Updated: Jan 29, 2026

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

932

Caveolin-1 as a pathophysiological factor and target in psoriasis.

Ilja L Kruglikov1, Philipp E Scherer2

  • 1Scientific Department, Wellcomet GmbH, Karlsruhe, Germany.

NPJ Aging and Mechanisms of Disease
|February 8, 2019
PubMed
Summary

Low caveolin-1 (Cav-1) expression worsens psoriasis. Modulating Cav-1 in skin and adipose tissue may treat psoriasis by reducing inflammation and skin thickening. Cav-1 is a potential therapeutic target.

More Related Videos

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.5K
Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
08:30

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation

Published on: August 14, 2017

11.8K

Related Experiment Videos

Last Updated: Jan 29, 2026

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

932
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.5K
Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
08:30

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation

Published on: August 14, 2017

11.8K

Area of Science:

  • Dermatology and Cell Biology

Background:

  • Low caveolin-1 (Cav-1) expression is characteristic of psoriatic lesions.
  • Increased Cav-1 expression can reduce inflammation and suppress epidermal hyperproliferation, key features of psoriasis.
  • Altered Cav-1 expression in white adipose tissue (WAT) adjacent to psoriatic lesions is suggested by increased tissue stiffness.

Purpose of the Study:

  • To explore the role of Cav-1 expression in psoriasis pathogenesis.
  • To analyze methods for spatially distinct modulation of Cav-1 expression in skin and WAT.
  • To identify Cav-1 as a potential therapeutic target for psoriasis.

Main Methods:

  • Discussion of existing literature on Cav-1 expression in psoriasis.
  • Analysis of exosomal exchange in connecting skin and WAT processes.
  • Consideration of pharmacological and physical factors for modulating Cav-1 expression.

Main Results:

  • Overexpression of Cav-1 ameliorates psoriasis hallmarks: inflammation and epidermal hyperproliferation.
  • Spatially differentiated modulation of Cav-1 in skin and WAT is achievable.
  • Mechanical stress and supra-physiological temperatures are potential inducers of Cav-1 modulation.

Conclusions:

  • Cav-1 plays a significant role in the inflammatory and hyperproliferative processes of psoriasis.
  • Targeting Cav-1 expression in both skin and adjacent adipose tissue presents a promising therapeutic strategy for psoriasis.
  • Cav-1 should be considered a key molecular target for future psoriasis treatments.